Continuous Subcutaneous Infusion of Compound Oxycodone for the Relief of Dyspnea in Patients With Terminally Ill Cancer: A Retrospective Study

American Journal of Hospice and Palliative Medicine

Volumn 30, Issue 3, 2013, Pages 305-311

  Kawabata, Masahiro ^a   Kaneishi, Keisuke ^a  

^a TOKYO KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

brain network; dyspnea; oxycodone; pain; rescues; subcutaneous injection

Indexed keywords

OXYCODONE;

AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; DYSPNEA; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; TERMINAL CARE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DYSPNEA; FEMALE; HUMANS; INFUSIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEOPLASMS; OXYCODONE; PAIN MANAGEMENT; RETROSPECTIVE STUDIES; TERMINAL CARE; TREATMENT OUTCOME;

EID: 84876250427     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909112448924     Document Type: Article

References (22)

1. Hanks GW,Conno F,Cherny N, et al.Expert Working Group of the Research Network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations.Br J Cancer. 2001;84 (5): 587-593.
2. International Narcotics Control Board. Narcotic Drugs 2011. http://www.incb.org/pdf/technical-reports/narcotic-drugs/2011/Narcotic_Drugs_Report_2011.pdf.
3. Watanabe S,Pereira J,Tarumi Y,Hanson J,Bruera E.A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.J Palliat Med. 2008;11 (4): 570-574.
4. Riley J,Eisenberg E,Müller-Schwefe G,Drewes AM,Arendt-Nielsen L.Oxycodone: a review of its use in the management of pain.Curr Med Res Opin. 2008;24 ((1)): 175-192.
5. Kokubun H,Fukawa M,Matoba M,Hoka S,Yamada Y,Yago K.Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain.Biol Pharm Bull. 2007;30 (11): 2173-2177.
6. Ito K,Kubota Y,Toda T,Suto S,Ikarashi N,Sugiyama K.Effect of hydrocotarnine on cytochrome P450 and P-glycoprotein.Drug Metab Pharmacokinet. 2009;24 (1): 108-113.
7. Kalso E,Vainio A.Morphine and oxycodone hydrochloride in the management of cancer pain.Clin Pharmacol Ther. 1990;47 (5): 639-646.
8. Maddocks I,Somogyi A,Abbott F,Hayball P,Parker D.Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.J Pain Symptom Manage. 1996;12 (3): 182-189.
9. Caraceni A,Cherny N,Fainsinger R.Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care.J Pain Symptom Manage. 2002;23 ((3)): 239-255.
10. Kalso E.Oxycodone.J Pain Symptom Manage. 2005;29 ((5)): S47-S56.
11. Niscola P,Scaramucci L,Vischini G, et al.The use of major analgesics in patients with renal dysfunction.Curr Drug Targets. 2010;11 (6): 752-758.
12. Hanks GW,Reid C.Contribution to variability in response to opioids.Support Care Cancer. 2005;13 ((3)): 145-152.
13. Ben-Aharon I,Gafter-Gvili A,Paul M,Leibovici L,Stemmer SM.Interventions for alleviating cancer-related dyspnea: a systematic review.J Clin Oncol. 2008;26 (14): 2396-2404.
14. Jennings AL,Davies AN,Higgins JP,Gibbs JS,Broadley KE.A systematic review of the use of opioids in the management of dyspnoea.Thorax. 2002;57 (11): 939-944.
15. Horton R,Rocker G.Contemporary issues in refractory dyspnoea in advanced chronic obstructive pulmonary disease.Curr Opin Support Palliat Care. 2010;4 (2): 56-62.
16. Clemens KE,Klaschik E.Effect of hydromorphone on ventilation in palliative care patients with dyspnea.Support Care Cancer. 2008;16 (1): 93-99.
17. Allen S,Raut S,Woollard J,Vassallo M.Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis.Palliat Med. 2005;19 (2): 128-130.
18. Gauna AA,Kang SK,Triano ML,Swatko ER,Vanston VJ.Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series.J Palliat Med. 2008;11 (4): 643-648.
19. Oxberry SG,Torgerson DJ,Bland JM,Clark AL,Cleland JG,Johnson MJ.Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial.Eur J Heart Fail. 2011;13 ((9)): 1006-1012.
20. Booth S,Moosavi SH,Higginson IJ.The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy.Nat Clin Pract Oncol. 2008;5 (2): 90-100.
21. von Leupoldt A,Sommer T,Kegat S, et al.Dyspnea and pain share emotion-related brain network.Neuroimage. 2009;48 (1): 200-206.
22. Mucci-LoRusso P,Berman BS,Silberstein PT, et al.Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study.Eur J Pain. 1998;2 (3): 239-249.